Who is sponsoring NCT03929276?

NCT03929276 is sponsored by Hitit University.

What drugs are being tested in NCT03929276?

Interventions in NCT03929276: high-intensity laser therapy & exercises, Shame laser & exercises, exercise.

What condition does NCT03929276 study?

NCT03929276 studies Adhesive Capsulitis of Shoulder.

Is NCT03929276 still recruiting?

NCT03929276 is currently completed. Last updated 28 April 2020.

Last reviewed 2020-04-28 · How we verify

NCT03929276

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Therapy in Adhesive Capsulitis

Completed NA Last updated 28 April 2020

What this trial tests

NA trial testing high-intensity laser therapy & exercises in Adhesive Capsulitis of Shoulder in 31 participants. Completed in 22 September 2019.

Timeline

22 April 2019

Primary endpoint
22 September 2019

22 September 2019

Quick facts

Lead sponsor	Hitit University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	31
Start date	22 April 2019
Primary completion	22 September 2019
Estimated completion	22 September 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

high-intensity laser therapy & exercises
Shame laser & exercises
exercise

Conditions studied

Adhesive Capsulitis of Shoulder — all drugs for Adhesive Capsulitis of Shoulder →

Sponsor

Hitit University

Who can join

Adults 18 to 65, any sex, with Adhesive Capsulitis of Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adhesive capsulitis is an idiopathic disease characterized by a decrease in the volume of the glenoid capsule, the development of fibrosis and a progressive decrease in the range of joint movement with pain. Shoulder pain and stiffness are accompanied by disability. The purpose of the study is to evaluate and compare the effects of high-intensity laser therapy on pain, disease - related disability and quality of life in patients with shoulder restriction and pain due to adhesive capsulitis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Efficacy of high-intensity laser therapy in patients with adhesive capsulitis: a sham-controlled randomized controlled trial.
Atan T, Bahar-Ozdemir Y. · · 2021 · cited 16× · PMID 32808147 · DOI 10.1007/s10103-020-03121-z
Assessment of therapeutic clinical trials for adhesive capsulitis of the shoulder.
Fares MY, Koa J, Abboud JA. · · 2023 · cited 3× · PMID 37266176 · DOI 10.1016/j.jseint.2023.01.003

Verify or expand the search:

Other recruiting trials for Adhesive Capsulitis of Shoulder

Currently open trials in the same condition.

NCT06686277 — Effects Of Gong's Versus Mulligan Mobilization In Patients With Adhesive Capsulitis · NA · recruiting
NCT05384093 — Outcomes of Treatment Using the ERMI Shoulder Flexionater ® · NA · recruiting

Other Hitit University trials

Trials by the same sponsor.

NCT07445269 — ACUTE EFFECTS OF INSPIRATORY MUSCLE WARM-UP ON INSPIRATORY MUSCLE STRENGTH DURING AEROBIC AND ANAEROBIC EXERCISE IN ATHL · NA · enrolling by invitation
NCT07101172 — The Effectiveness of Stress Ball in Managing Anxiety and Pain During Prostate Biopsy · NA · enrolling by invitation
NCT07527065 — Comparison of TAP and QL Blocks for Postoperative Analgesia in Open Inguinal Hernia Repair · NA · enrolling by invitation
NCT06981520 — Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF · not yet recruiting
NCT07037602 — Sexual Health Education Given to Women · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03929276 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hitit University
Last refreshed: 28 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03929276.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing